Google Search

News

綜合報道
卑詩愛滋病/愛滋病毒卓越研究中心(BC Centre for Excellence in HIV/AIDS)與中國疾病控制與預防中心(Chinese Centre for Disease Control and Prevention)，再次簽署協議，共同研究和改良愛滋病治療方法，中國疾控中心將繼續推廣使用由卑詩省研發的「治療如同預防」（Treatment as Prevention）的對抗愛滋病方法。

The Brumme laboratory at SFU and the BC Centre for Excellence in HIV/AIDS integrates molecular biology, epidemiology and computational approaches to examine questions at the interface of HIV virology, immunology and pathogenesis with the ultimate goal of preventing and curing HIV infection.

The past few years have been a rollercoaster for those of us most impacted by HIV. The use of pre-exposure prophylaxis (PrEP) by people who are HIV-negative has gone from being discredited and shamed to become one of the keystones of a renewed and revitalized push to “end the HIV epidemic”. The other life-changing piece of research is the landmark PARTNER study that showed us, once and for all, that the sexual transmission of HIV does not occur in people whose viral loads are undetectable. The joyous global uptake of the U=U message has been nothing short of inspirational.

Enacted in 1989, Illinois' HIV Criminal Transmission Law has undergone minor revisions since then, but remains no less controversial. In the era of U=U (Undetectable=Untransmittable), PrEP, treatment as prevention (TasP, e.g., HPTN 052 and other studies), as well as enlightenment about HIV in general, it is time to reconsider the consequences of this law.

(CNN) HIV pre-exposure prophylaxis or PrEP, the use of drugs to prevent HIV infection, among men who have sex with men can significantly reduce new infections across an entire population of men, a new study finds.

In a fast-evolving fight against HIV, public-health workers have a powerful new ally: Most Americans at risk of contracting the virus carry powerful smartphones that they check again and again over the course of the day.

The ADAP Advocacy Association hosted its annual conference in late September, and it covered many subject areas along this year's official theme, "Mapping a New Course to Protect the Public Health Safety Net." The AIDS Drug Assistance Program, which was first established by Congress to pay for Retrovir (zidovudine, AZT) in 1987, was then incorporated into the Ryan White Care Act, which passed in 1990.